MindWalk (HYFT) vs Spero Therapeutics (SPRO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
MindWalk (HYFT) has outperformed Spero Therapeutics (SPRO) over the past year, losing 20.2% versus a loss of 45.8%. Over five years, HYFT leads with a -77.2% price change compared with -93.1% for SPRO. MindWalk is the larger company by market cap ($69.3 million vs $68.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HYFT | SPRO |
|---|---|---|
| Share price | $1.47 | $1.17 |
| Market cap | $69.25M | $68.13M |
| 1-day change | -2.00% | 0.00% |
| YTD return | -17.58% | -49.79% |
| 1-year return | -20.21% | -45.83% |
| 5-year return | -77.20% | -93.13% |
| P/E ratio (TTM) | — | 8.36 |
| EPS (TTM) | $-0.26 | $0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.99 | $3.08 |
| 52-week low | $0.99 | $1.08 |
| Distance from 52-week high | -50.84% | -62.01% |
| Average volume | 225.20K | 1.20M |
| Shares outstanding | 47.11M | 58.23M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HYFT has outperformed SPRO by 25.6 percentage points over the past year.
HYFT vs SPRO FAQ
Which is bigger, MindWalk or Spero Therapeutics?
MindWalk (HYFT) is larger, with a market capitalization of $69.25M compared with $68.13M for Spero Therapeutics (SPRO).
Which stock has performed better over the past year, HYFT or SPRO?
HYFT returned -20.21% over the past 12 months, compared with -45.83% for SPRO (price return, excluding dividends). Past performance does not predict future results.
Are MindWalk and Spero Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.